{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:47:06Z","timestamp":1792590426840,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HA 9949\/1-1"],"award-info":[{"award-number":["HA 9949\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-03912-2","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:21:44Z","timestamp":1683768104000},"page":"2449-2455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["mpMRI Interpretation in Active Surveillance for Prostate Cancer\u2014An overview of the PRECISE score"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3182-5924","authenticated-orcid":false,"given":"Felix N.","family":"Harder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina A. M.","family":"Heming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoom A.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"3912_CR1","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1002\/cncr.28301","volume":"119","author":"JD Brooks","year":"2013","unstructured":"J.D. Brooks, Managing localized prostate cancer in the era of prostate-specific antigen screening, Cancer. 119 (2013) 3906\u20133909. https:\/\/doi.org\/10.1002\/cncr.28301.","journal-title":"Cancer."},{"key":"3912_CR2","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1200\/JCO.2011.34.9738","volume":"29","author":"MR Cooperberg","year":"2011","unstructured":"M.R. Cooperberg, P.R. Carroll, L. Klotz, Active Surveillance for Prostate Cancer: Progress and Promise, J. Clin. Oncol. 29 (2011) 3669\u20133676. https:\/\/doi.org\/10.1200\/JCO.2011.34.9738.","journal-title":"J. Clin. Oncol."},{"key":"3912_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"N. Mottet, R.C.N. van den Bergh, E. Briers, T. Van den Broeck, M.G. Cumberbatch, M. De Santis, S. Fanti, N. Fossati, G. Gandaglia, S. Gillessen, N. Grivas, J. Grummet, A.M. Henry, T.H. van der Kwast, T.B. Lam, M. Lardas, M. Liew, M.D. Mason, L. Moris, D.E. Oprea-Lager, H.G. van der Poel, O. Rouvi\u00e8re, I.G. Schoots, D. Tilki, T. Wiegel, P.-P.M. Willemse, P. Cornford, EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent, Eur. Urol. 79 (2021) 243\u2013262. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042.","journal-title":"Eur. Urol."},{"key":"3912_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/JU.0000000000002758","volume":"208","author":"JA Eastham","year":"2022","unstructured":"J.A. Eastham, G.B. Auffenberg, D.A. Barocas, R. Chou, T. Crispino, J.W. Davis, S. Eggener, E.M. Horwitz, C.J. Kane, E. Kirkby, D.W. Lin, S.M. McBride, A.K. Morgans, P.M. Pierorazio, G. Rodrigues, W.W. Wong, S.A. Boorjian, Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up, J. Urol. 208 (2022) 19\u201325. https:\/\/doi.org\/10.1097\/JU.0000000000002758.","journal-title":"J. Urol."},{"key":"3912_CR5","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1200\/JCO.2015.65.7759","volume":"34","author":"RC Chen","year":"2016","unstructured":"R.C. Chen, R.B. Rumble, D.A. Loblaw, A. Finelli, B. Ehdaie, M.R. Cooperberg, S.C. Morgan, S. Tyldesley, J.J. Haluschak, W. Tan, S. Justman, S. Jain, Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement, J. Clin. Oncol. 34 (2016) 2182\u20132190. https:\/\/doi.org\/10.1200\/JCO.2015.65.7759.","journal-title":"J. Clin. Oncol."},{"issue":"2019","key":"3912_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bju.14809","volume":"124","author":"NICE Guidance-Prostate cancer: diagnosis and management: \u00a9 NICE","year":"2019","unstructured":"NICE Guidance - Prostate cancer: diagnosis and management: \u00a9 NICE (2019) Prostate cancer: diagnosis and management, BJU Int. 124 (2019) 9\u201326. https:\/\/doi.org\/10.1111\/bju.14809.","journal-title":"BJU Int."},{"key":"3912_CR7","doi-asserted-by":"publisher","first-page":"f7524","DOI":"10.1136\/bmj.f7524","volume":"348","author":"J Graham","year":"2014","unstructured":"J. Graham, P. Kirkbride, K. Cann, E. Hasler, M. Prettyjohns, Prostate cancer: summary of updated NICE guidance, BMJ. 348 (2014) f7524. https:\/\/doi.org\/10.1136\/bmj.f7524.","journal-title":"BMJ."},{"key":"3912_CR8","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.6004\/jnccn.2022.0063","volume":"20","author":"EM Schaeffer","year":"2022","unstructured":"E.M. Schaeffer, S. Srinivas, N. Adra, Y. An, D. Barocas, R. Bitting, A. Bryce, B. Chapin, H.H. Cheng, A.V. D\u2019Amico, N. Desai, T. Dorff, J.A. Eastham, T.A. Farrington, X. Gao, S. Gupta, T. Guzzo, J.E. Ippolito, M.R. Kuettel, J.M. Lang, T. Lotan, R.R. McKay, T. Morgan, G. Netto, J.M. Pow-Sang, R. Reiter, M. Roach, T. Robin, S. Rosenfeld, A. Shabsigh, D. Spratt, B.A. Teply, J. Tward, R. Valicenti, J.K. Wong, R.A. Berardi, D.A. Shead, D.A. Freedman-Cass, NCCN Guidelines\u00ae Insights: Prostate Cancer, Version 1.2023, J. Natl. Compr. Cancer Netw. JNCCN. 20 (2022) 1288\u20131298. https:\/\/doi.org\/10.6004\/jnccn.2022.0063.","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN."},{"key":"3912_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.01.003","author":"CM Moore","year":"2023","unstructured":"C.M. Moore, L.E. King, J. Withington, M.B. Amin, M. Andrews, E. Briers, R.C. Chen, F.I. Chinegwundoh, M.R. Cooperberg, J. Crowe, A. Finelli, M.I. Fitch, M. Frydenberg, F. Giganti, M.A. Haider, J. Freeman, J. Gallo, S. Gibbs, A. Henry, N. James, N. Kinsella, T.B.L. Lam, M. Lichty, S. Loeb, B.A. Mahal, K. Mastris, A.V. Mitra, S.W.D. Merriel, T. van der Kwast, M. Van Hemelrijck, N.R. Palmer, C.C. Paterson, M.J. Roobol, P. Segal, J.A. Schraidt, C.E. Short, M.M. Siddiqui, C.M.C. Tempany, A. Villers, H. Wolinsky, S. MacLennan, Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer\u2014A Report of a Movember International Consensus Meeting, Eur. Urol. Oncol. (2023). https:\/\/doi.org\/10.1016\/j.euo.2023.01.003.","journal-title":"Eur. Urol. Oncol."},{"key":"3912_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/bju.14358","volume":"122","author":"IG Schoots","year":"2018","unstructured":"I.G. Schoots, D. Nieboer, F. Giganti, C.M. Moore, C.H. Bangma, M.J. Roobol, Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis, BJU Int. 122 (2018) 946\u2013958. https:\/\/doi.org\/10.1111\/bju.14358.","journal-title":"BJU Int."},{"key":"3912_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41391-018-0077-2","volume":"22","author":"V Stavrinides","year":"2019","unstructured":"V. Stavrinides, F. Giganti, M. Emberton, C.M. Moore, MRI in active surveillance: a critical review, Prostate Cancer Prostatic Dis. 22 (2019) 5\u201315. https:\/\/doi.org\/10.1038\/s41391-018-0077-2.","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"3912_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2214\/AJR.16.16355","volume":"208","author":"T Barrett","year":"2017","unstructured":"T. Barrett, M.A. Haider, The Emerging Role of MRI in Prostate Cancer Active Surveillance and Ongoing Challenges, Am. J. Roentgenol. 208 (2017) 131\u2013139. https:\/\/doi.org\/10.2214\/AJR.16.16355.","journal-title":"Am. J. Roentgenol."},{"key":"3912_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/JU.0000000000001519","volume":"205","author":"T Stonier","year":"2021","unstructured":"T. Stonier, A.L. Tin, D.D. Sjoberg, G. Jibara, A.J. Vickers, S. Fine, J. Eastham, Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?, J. Urol. 205 (2021) 1063\u20131068. https:\/\/doi.org\/10.1097\/JU.0000000000001519.","journal-title":"J. Urol."},{"key":"3912_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.euf.2019.03.001","volume":"7","author":"S Dieffenbacher","year":"2021","unstructured":"S. Dieffenbacher, J. Nyarangi-Dix, F. Giganti, D. Bonekamp, C. Kesch, M.B. M\u00fcller-Wolf, V. Sch\u00fctz, C. Gasch, G. Hatiboglu, M. Hauffe, A. Stenzinger, S. Duensing, H.-P. Schlemmer, C.M. Moore, M. Hohenfellner, J.P. Radtke, Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging\/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance, Eur. Urol. Focus. 7 (2021) 102\u2013110. https:\/\/doi.org\/10.1016\/j.euf.2019.03.001.","journal-title":"Eur. Urol. Focus."},{"key":"3912_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.eururo.2019.10.007","volume":"77","author":"L Klotz","year":"2020","unstructured":"L. Klotz, G. Pond, A. Loblaw, L. Sugar, M. Moussa, D. Berman, T. Van der Kwast, D. Vesprini, L. Milot, M. Kebabdjian, N. Fleshner, S. Ghai, J. Chin, M. Haider, Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up, Eur. Urol. 77 (2020) 311\u2013317. https:\/\/doi.org\/10.1016\/j.eururo.2019.10.007.","journal-title":"Eur. Urol."},{"key":"3912_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/JU.0000000000000693","volume":"203","author":"A Amin","year":"2020","unstructured":"A. Amin, M.J. Scheltema, R. Shnier, A. Blazevski, D. Moses, T. Cusick, A. Siriwardena, B. Yuen, P.J. van Leeuwen, A.M. Haynes, J. Matthews, P. Brenner, G. O\u2019Neill, C. Yuen, W. Delprado, P. Stricker, J. Thompson, The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies, J. Urol. 203 (2020) 910\u2013917. https:\/\/doi.org\/10.1097\/JU.0000000000000693.","journal-title":"J. Urol."},{"key":"3912_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.eururo.2020.03.035","volume":"78","author":"V Stavrinides","year":"2020","unstructured":"V. Stavrinides, F. Giganti, B. Trock, S. Punwani, C. Allen, A. Kirkham, A. Freeman, A. Haider, R. Ball, N. McCartan, H. Whitaker, C. Orczyk, M. Emberton, C.M. Moore, Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study, Eur. Urol. 78 (2020) 443\u2013451. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.035.","journal-title":"Eur. Urol."},{"key":"3912_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.juro.2015.01.088","volume":"193","author":"MM Siddiqui","year":"2015","unstructured":"M.M. Siddiqui, H. Truong, S. Rais-Bahrami, L. Stamatakis, J. Logan, A. Walton-Diaz, B. Turkbey, P.L. Choyke, B.J. Wood, R.M. Simon, P.A. Pinto, Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance, J. Urol. 193 (2015) 1943\u20131949. https:\/\/doi.org\/10.1016\/j.juro.2015.01.088.","journal-title":"J. Urol."},{"key":"3912_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.euf.2017.12.008","volume":"5","author":"EHJ Hamoen","year":"2019","unstructured":"E.H.J. Hamoen, C.M.A. Hoeks, D.M. Somford, I.M. van Oort, H. Vergunst, J.R. Oddens, G.A. Smits, L.P. Bokhorst, J.A. Witjes, M.M. Rovers, C.A. Hulsbergen-van de Kaa, J.O. Barentsz, Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up, Eur. Urol. Focus. 5 (2019) 407\u2013415. https:\/\/doi.org\/10.1016\/j.euf.2017.12.008.","journal-title":"Eur. Urol. Focus."},{"key":"3912_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/21681805.2017.1409265","volume":"52","author":"MC Elkj\u00e6r","year":"2018","unstructured":"M.C. Elkj\u00e6r, M.H. Andersen, S. H\u00f8yer, B.G. Pedersen, M. Borre, Multi-parametric magnetic resonance imaging monitoring patients in active surveillance for prostate cancer: a prospective cohort study, Scand. J. Urol. 52 (2018) 8\u201313. https:\/\/doi.org\/10.1080\/21681805.2017.1409265.","journal-title":"J. Urol."},{"key":"3912_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/bju.15065","volume":"126","author":"DF Osses","year":"2020","unstructured":"D.F. Osses, F.-J.H. Drost, J.F.M. Verbeek, H.B. Luiting, G.J.L.H. van Leenders, C.H. Bangma, G.P. Krestin, M.J. Roobol, I.G. Schoots, Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?, BJU Int. 126 (2020) 124\u2013132. https:\/\/doi.org\/10.1111\/bju.15065.","journal-title":"BJU Int."},{"key":"3912_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.eururo.2019.12.009","volume":"77","author":"GT Chesnut","year":"2020","unstructured":"G.T. Chesnut, E.A. Vertosick, N. Benfante, D.D. Sjoberg, J. Fainberg, T. Lee, J. Eastham, V. Laudone, P. Scardino, K. Touijer, A. Vickers, B. Ehdaie, Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance, Eur. Urol. 77 (2020) 501\u2013507. https:\/\/doi.org\/10.1016\/j.eururo.2019.12.009.","journal-title":"Eur. Urol."},{"issue":"2019","key":"3912_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"B. Turkbey, A.B. Rosenkrantz, M.A. Haider, A.R. Padhani, G. Villeirs, K.J. Macura, C.M. Tempany, P.L. Choyke, F. Cornud, D.J. Margolis, H.C. Thoeny, S. Verma, J. Barentsz, J.C. Weinreb, Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2, Eur. Urol. 76 (2019) 340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033.","journal-title":"Eur. Urol."},{"key":"3912_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","volume":"71","author":"CM Moore","year":"2017","unstructured":"C.M. Moore, F. Giganti, P. Albertsen, C. Allen, C. Bangma, A. Briganti, P. Carroll, M. Haider, V. Kasivisvanathan, A. Kirkham, L. Klotz, A. Ouzzane, A.R. Padhani, V. Panebianco, P. Pinto, P. Puech, A. Rannikko, R. Renard-Penna, K. Touijer, B. Turkbey, H. van Poppel, R. Valdagni, J. Walz, I. Schoots, Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force, Eur. Urol. 71 (2017) 648\u2013655. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.011.","journal-title":"Eur. Urol."},{"key":"3912_CR25","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1007\/s00330-020-07336-0","volume":"31","author":"I Caglic","year":"2021","unstructured":"I. Caglic, N. Sushentsev, V.J. Gnanapragasam, E. Sala, N. Shaida, B.C. Koo, V. Kozlov, A.Y. Warren, C. Kastner, T. Barrett, MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance, Eur. Radiol. 31 (2021) 2696\u20132705. https:\/\/doi.org\/10.1007\/s00330-020-07336-0.","journal-title":"Eur. Radiol."},{"key":"3912_CR26","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1007\/s00330-020-07256-z","volume":"31","author":"F Giganti","year":"2021","unstructured":"F. Giganti, A. Stabile, V. Stavrinides, E. Osinibi, A. Retter, C. Orczyk, V. Panebianco, B.J. Trock, A. Freeman, A. Haider, S. Punwani, C. Allen, A. Kirkham, M. Emberton, C.M. Moore, Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort, Eur. Radiol. 31 (2021) 1644\u20131655. https:\/\/doi.org\/10.1007\/s00330-020-07256-z.","journal-title":"Eur. Radiol."},{"key":"3912_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.euo.2020.09.004","volume":"4","author":"LP O\u2019Connor","year":"2021","unstructured":"L.P. O\u2019Connor, A.Z. Wang, N.K. Yerram, L. Long, M. Ahdoot, A.H. Lebastchi, S. Gurram, J. Zeng, S.A. Harmon, S. Mehralivand, M.J. Merino, H.L. Parnes, P.L. Choyke, J.H. Shih, B.J. Wood, B. Turkbey, P.A. Pinto, Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance, Eur. Urol. Oncol. 4 (2021) 227\u2013234. https:\/\/doi.org\/10.1016\/j.euo.2020.09.004.","journal-title":"Eur. Urol. Oncol."},{"key":"3912_CR28","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1007\/s00330-020-06997-1","volume":"30","author":"T Ullrich","year":"2020","unstructured":"T. Ullrich, C. Arsov, M. Quentin, F. Mones, A.C. Westphalen, D. Mally, A. Hiester, P. Albers, G. Antoch, L. Schimm\u00f6ller, Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study, Eur. Radiol. 30 (2020) 6042\u20136051. https:\/\/doi.org\/10.1007\/s00330-020-06997-1.","journal-title":"Eur. Radiol."},{"key":"3912_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2021.01.016","volume":"79","author":"F Giganti","year":"2021","unstructured":"F. Giganti, V. Kasivisvanathan, C. Allen, C.M. Moore, The Importance of Being PRECISE in Prostate Magnetic Resonance Imaging and Active Surveillance, Eur. Urol. 79 (2021) 560\u2013563. https:\/\/doi.org\/10.1016\/j.eururo.2021.01.016.","journal-title":"Eur. Urol."},{"key":"3912_CR30","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00330-019-06557-2","volume":"30","author":"F Giganti","year":"2020","unstructured":"F. Giganti, M. Pecoraro, V. Stavrinides, A. Stabile, S. Cipollari, A. Sciarra, A. Kirkham, C. Allen, S. Punwani, M. Emberton, C. Catalano, C.M. Moore, V. Panebianco, Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study, Eur. Radiol. 30 (2020) 2082\u20132090. https:\/\/doi.org\/10.1007\/s00330-019-06557-2.","journal-title":"Eur. Radiol."},{"key":"3912_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13244-022-01252-1","volume":"13","author":"F Giganti","year":"2022","unstructured":"F. Giganti, L. Aupin, C. Thoumin, I. Faouzi, H. Monnier, M. Fontaine, A. Navidi, P.-G. Ritvo, V. Ong, C. Chung, I. Bibi, R. Lehrer, N. Hermieu, E. Barret, A. Ambrosi, V. Kasivisvanathan, M. Emberton, C. Allen, A. Kirkham, C.M. Moore, R. Renard-Penna, Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship, Insights Imaging. 13 (2022) 111. https:\/\/doi.org\/10.1186\/s13244-022-01252-1.","journal-title":"Insights Imaging."},{"key":"3912_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mri.2018.10.013","volume":"57","author":"F Giganti","year":"2019","unstructured":"F. Giganti, C. Allen, J.W. Piper, D. Mirando, A. Stabile, S. Punwani, A. Kirkham, M. Emberton, C.M. Moore, Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program, Magn. Reson. Imaging. 57 (2019) 34\u201339. https:\/\/doi.org\/10.1016\/j.mri.2018.10.013.","journal-title":"Magn. Reson. Imaging."},{"key":"3912_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1148\/radiol.13121325","volume":"268","author":"B Turkbey","year":"2013","unstructured":"B. Turkbey, H. Mani, O. Aras, J. Ho, A. Hoang, A.R. Rastinehad, H. Agarwal, V. Shah, M. Bernardo, Y. Pang, D. Daar, Y.L. McKinney, W.M. Linehan, A. Kaushal, M.J. Merino, B.J. Wood, P.A. Pinto, P.L. Choyke, Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?, Radiology. 268 (2013) 144\u2013152. https:\/\/doi.org\/10.1148\/radiol.13121325.","journal-title":"Radiology."},{"key":"3912_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13014-022-02035-0","volume":"17","author":"DD Gunashekar","year":"2022","unstructured":"D.D. Gunashekar, L. Bielak, L. H\u00e4gele, B. Oerther, M. Benndorf, A.-L. Grosu, T. Brox, C. Zamboglou, M. Bock, Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology, Radiat. Oncol. 17 (2022) 65. https:\/\/doi.org\/10.1186\/s13014-022-02035-0.","journal-title":"Radiat. Oncol."},{"key":"3912_CR35","doi-asserted-by":"publisher","first-page":"20200819","DOI":"10.1259\/bjr.20200819","volume":"93","author":"F Giganti","year":"2020","unstructured":"F. Giganti, V. Stavrinides, A. Stabile, E. Osinibi, C. Orczyk, J.P. Radtke, A. Freeman, A. Haider, S. Punwani, C. Allen, M. Emberton, A. Kirkham, C.M. Moore, Prostate cancer measurements on serial MRI during active surveillance: it\u2019s time to be PRECISE, Br. J. Radiol. 93 (2020) 20200819. https:\/\/doi.org\/10.1259\/bjr.20200819.","journal-title":"Br. J. Radiol."},{"key":"3912_CR36","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1007\/s00330-020-07494-1","volume":"31","author":"NA Huebner","year":"2021","unstructured":"N.A. Huebner, S. Korn, I. Resch, B. Grubm\u00fcller, T. Gross, R. Gale, G. Kramer, N. Poetsch, P. Clauser, A. Haitel, H. Fajkovic, S.F. Shariat, P.A. Baltzer, Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)\u2014do we still need contrast media?, Eur. Radiol. 31 (2021) 3754\u20133764. https:\/\/doi.org\/10.1007\/s00330-020-07494-1.","journal-title":"Eur. Radiol."},{"key":"3912_CR37","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1007\/s00330-017-4858-0","volume":"27","author":"F Giganti","year":"2017","unstructured":"F. Giganti, C.M. Moore, N.L. Robertson, N. McCartan, C. Jameson, S.R.J. Bott, M. Winkler, G. Gambarota, B. Whitcher, R. Castro, M. Emberton, C. Allen, A. Kirkham, MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial, Eur. Radiol. 27 (2017) 4767\u20134774. https:\/\/doi.org\/10.1007\/s00330-017-4858-0.","journal-title":"Eur. Radiol."},{"key":"3912_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1148\/radiol.2017170129","volume":"285","author":"CK Kuhl","year":"2017","unstructured":"C.K. Kuhl, R. Bruhn, N. Kr\u00e4mer, S. Nebelung, A. Heidenreich, S. Schrading, Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen, Radiology. 285 (2017) 493\u2013505. https:\/\/doi.org\/10.1148\/radiol.2017170129.","journal-title":"Radiology."},{"key":"3912_CR39","doi-asserted-by":"publisher","first-page":"12917","DOI":"10.1038\/s41598-021-92341-6","volume":"11","author":"N Sushentsev","year":"2021","unstructured":"N. Sushentsev, L. Rundo, O. Blyuss, V.J. Gnanapragasam, E. Sala, T. Barrett, MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance, Sci. Rep. 11 (2021) 12917. https:\/\/doi.org\/10.1038\/s41598-021-92341-6.","journal-title":"Sci. Rep."},{"key":"3912_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25983","author":"A Algohary","year":"2018","unstructured":"A. Algohary, S. Viswanath, R. Shiradkar, S. Ghose, S. Pahwa, D. Moses, I. Jambor, R. Shnier, M. B\u00f6hm, A.-M. Haynes, P. Brenner, W. Delprado, J. Thompson, M. Pulbrock, A.S. Purysko, S. Verma, L. Ponsky, P. Stricker, A. Madabhushi, Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings, J. Magn. Reson. Imaging JMRI. (2018). https:\/\/doi.org\/10.1002\/jmri.25983.","journal-title":"J. Magn. Reson. Imaging JMRI."},{"key":"3912_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1148\/radiol.2019190938","volume":"293","author":"P Schelb","year":"2019","unstructured":"P. Schelb, S. Kohl, J.P. Radtke, M. Wiesenfarth, P. Kickingereder, S. Bickelhaupt, T.A. Kuder, A. Stenzinger, M. Hohenfellner, H.-P. Schlemmer, K.H. Maier-Hein, D. Bonekamp, Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment, Radiology. 293 (2019) 607\u2013617. https:\/\/doi.org\/10.1148\/radiol.2019190938.","journal-title":"Radiology."},{"key":"3912_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mri.2019.12.007","volume":"67","author":"F Giganti","year":"2020","unstructured":"F. Giganti, M. Pecoraro, D. Fierro, R. Campa, F. Del Giudice, S. Punwani, A. Kirkham, C. Allen, M. Emberton, C. Catalano, C.M. Moore, V. Panebianco, DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations, Magn. Reson. Imaging. 67 (2020) 50\u201358. https:\/\/doi.org\/10.1016\/j.mri.2019.12.007.","journal-title":"Magn. Reson. Imaging."},{"key":"3912_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1259\/bjr\/14556365","volume":"84","author":"VA Morgan","year":"2011","unstructured":"V.A. Morgan, S.F. Riches, K. Thomas, N. Vanas, C. Parker, S. Giles, N.M. Desouza, Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance, Br. J. Radiol. 84 (2011) 31\u201337. https:\/\/doi.org\/10.1259\/bjr\/14556365.","journal-title":"Br. J. Radiol."},{"key":"3912_CR44","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1016\/j.clgc.2020.04.006","volume":"18","author":"M Roscigno","year":"2020","unstructured":"M. Roscigno, A. Stabile, G. Lughezzani, P. Pepe, A.B. Galosi, A. Naselli, R. Naspro, M. Nicolai, G.L. Croce, M. Aljoulani, G. Perugini, G. Guazzoni, F. Montorsi, L. Balzarini, S. Sironi, L.F.D. Pozzo, The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?, Clin. Genitourin. Cancer. 18 (2020) e698\u2013e704. https:\/\/doi.org\/10.1016\/j.clgc.2020.04.006.","journal-title":"Clin. Genitourin. Cancer."},{"key":"3912_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41391-021-00373-w","volume":"24","author":"V Stavrinides","year":"2021","unstructured":"V. Stavrinides, G. Papageorgiou, D. Danks, F. Giganti, N. Pashayan, B. Trock, A. Freeman, Y. Hu, H. Whitaker, C. Allen, A. Kirkham, S. Punwani, G. Sonn, D. Barratt, M. Emberton, C.M. Moore, Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models, Prostate Cancer Prostatic Dis. 24 (2021) 1028\u20131031. https:\/\/doi.org\/10.1038\/s41391-021-00373-w.","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"3912_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiol.2021204112","volume":"300","author":"D Deniffel","year":"2021","unstructured":"D. Deniffel, G.M. Healy, X. Dong, S. Ghai, E. Salinas-Miranda, N. Fleshner, R. Hamilton, G. Kulkarni, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, N. Perlis, M.A. Haider, Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer, Radiology. 300 (2021) 369\u2013379. https:\/\/doi.org\/10.1148\/radiol.2021204112.","journal-title":"Radiology."},{"key":"3912_CR47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/bju.13619","volume":"119","author":"NL Hansen","year":"2017","unstructured":"N.L. Hansen, T. Barrett, B. Koo, A. Doble, V. Gnanapragasam, A. Warren, C. Kastner, O. Bratt, The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting, BJU Int. 119 (2017) 724\u2013730. https:\/\/doi.org\/10.1111\/bju.13619.","journal-title":"BJU Int."},{"key":"3912_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2214\/AJR.20.23985","volume":"216","author":"F Giganti","year":"2021","unstructured":"F. Giganti, A. Kirkham, C. Allen, S. Punwani, C. Orczyk, M. Emberton, C.M. Moore, Update on Multiparametric Prostate MRI During Active Surveillance: Current and Future Trends and Role of the PRECISE Recommendations, Am. J. Roentgenol. 216 (2021) 943\u2013951. https:\/\/doi.org\/10.2214\/AJR.20.23985.","journal-title":"Am. J. Roentgenol."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-03912-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T02:05:49Z","timestamp":1685412349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-03912-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-03912-2","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}